Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18070
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKanaan, Richard A A-
dc.contributor.authorPicchioni, Marco M-
dc.contributor.authorMcDonald, Colm-
dc.contributor.authorShergill, Sukhwinder S-
dc.contributor.authorMcGuire, Philip K-
dc.date2017-04-06-
dc.date.accessioned2018-07-10T06:34:25Z-
dc.date.available2018-07-10T06:34:25Z-
dc.date.issued2017-10-
dc.identifier.citationThe Australian and New Zealand Journal of Psychiatry 2017; 51(10): 1020-1031-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18070-
dc.description.abstractDiffusion tensor imaging has revealed differences in all examined white matter tracts in schizophrenia, with a range of explanations for why this may be. The distribution and timing of differences may help explain their origin; however, results are usually dependent on the analytical method. We therefore sought to examine the extent of differences and their relationship with age using two different methods. A combined voxel-based whole-brain study and a tract-based spatial-statistics study of 104 patients with schizophrenia and 200 matched healthy controls, aged between 17 and 63 years. Fractional anisotropy was reduced throughout the brain in both analyses. The relationship of fractional anisotropy with age differed between patients and controls, with controls showing the gentle fractional anisotropy decline widely noted but patients showing an essentially flat relationship: younger patients had lower fractional anisotropy than controls, but the difference disappeared with age. Mean diffusivity was widely increased in patients. Reduction in fractional anisotropy and increase in mean diffusivity would be consistent with global disruption in myelination; the relationship with age would suggest this is present already at the onset of their illness, but does not progress.-
dc.language.isoeng-
dc.subjectDTI-
dc.subjectDiffusion tensor imaging-
dc.subjectTBSS-
dc.subjectantipsychotic medication-
dc.subjectillness duration-
dc.titleWhite matter deficits in schizophrenia are global and don't progress with age.-
dc.typeJournal Article-
dc.identifier.journaltitleThe Australian and New Zealand Journal of Psychiatry-
dc.identifier.affiliationDepartment of Psychiatry, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.affiliationDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK-
dc.identifier.affiliationSt Andrew's Academic Department and King's College London, Northampton, UK-
dc.identifier.affiliationNational University of Ireland (NUI), Galway, Ireland-
dc.identifier.doi10.1177/0004867417700729-
dc.identifier.orcid0000-0003-0992-1917-
dc.identifier.pubmedid28382844-
dc.type.austinJournal Article-
local.name.researcherKanaan, Richard A A
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptPsychiatry (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Jan 1, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.